Improving Rhode Island's Tuberculosis Preventive Services in Primary Care
Condition:   Latent Tuberculosis Intervention:   Other: TB Infection ECHO Sponsors:   Kent Hospital, Rhode Island;   National Institute of General Medical Sciences (NIGMS) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Increasing Notifications of Tuberculosis From Private Practitioners
Condition:   Tuberculosis Intervention:   Other: INSTEP2 intervention package Sponsors:   Universitas Padjadjaran;   University of Otago;   Harvard University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Moxifloxacin, Isoniazid, Rifampicin;   Drug: Rifampicin,Isoniazid,Pyrazinamide,Ethambutol Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Improving Rhode Island's Tuberculosis Preventive Services in Primary Care
Condition:   Latent Tuberculosis Intervention:   Other: TB Infection ECHO Sponsors:   Kent Hospital, Rhode Island;   National Institute of General Medical Sciences (NIGMS) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Moxifloxacin, Isoniazid, Rifampicin;   Drug: Rifampicin,Isoniazid,Pyrazinamide,Ethambutol Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Increasing Notifications of Tuberculosis From Private Practitioners
Condition:   Tuberculosis Intervention:   Other: INSTEP2 intervention package Sponsors:   Universitas Padjadjaran;   University of Otago;   Harvard University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Improving Rhode Island's Tuberculosis Preventive Services in Primary Care
Condition:   Latent Tuberculosis Intervention:   Other: TB Infection ECHO Sponsors:   Kent Hospital, Rhode Island;   National Institute of General Medical Sciences (NIGMS) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Moxifloxacin, Isoniazid, Rifampicin;   Drug: Rifampicin,Isoniazid,Pyrazinamide,Ethambutol Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Increasing Notifications of Tuberculosis From Private Practitioners
Condition:   Tuberculosis Intervention:   Other: INSTEP2 intervention package Sponsors:   Universitas Padjadjaran;   University of Otago;   Harvard University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Moxifloxacin, Isoniazid, Rifampicin;   Drug: Rifampicin,Isoniazid,Pyrazinamide,Ethambutol Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Improving Rhode Island's Tuberculosis Preventive Services in Primary Care
Condition:   Latent Tuberculosis Intervention:   Other: TB Infection ECHO Sponsors:   Kent Hospital, Rhode Island;   National Institute of General Medical Sciences (NIGMS) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Increasing Notifications of Tuberculosis From Private Practitioners
Condition:   Tuberculosis Intervention:   Other: INSTEP2 intervention package Sponsors:   Universitas Padjadjaran;   University of Otago;   Harvard University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Moxifloxacin, Isoniazid, Rifampicin;   Drug: Rifampicin,Isoniazid,Pyrazinamide,Ethambutol Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Improving Rhode Island's Tuberculosis Preventive Services in Primary Care
Condition:   Latent Tuberculosis Intervention:   Other: TB Infection ECHO Sponsors:   Kent Hospital, Rhode Island;   National Institute of General Medical Sciences (NIGMS) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Increasing Notifications of Tuberculosis From Private Practitioners
Condition:   Tuberculosis Intervention:   Other: INSTEP2 intervention package Sponsors:   Universitas Padjadjaran;   University of Otago;   Harvard University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Moxifloxacin, Isoniazid, Rifampicin;   Drug: Rifampicin,Isoniazid,Pyrazinamide,Ethambutol Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Improving Rhode Island's Tuberculosis Preventive Services in Primary Care
Condition:   Latent Tuberculosis Intervention:   Other: TB Infection ECHO Sponsors:   Kent Hospital, Rhode Island;   National Institute of General Medical Sciences (NIGMS) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Increasing Notifications of Tuberculosis From Private Practitioners
Condition:   Tuberculosis Intervention:   Other: INSTEP2 intervention package Sponsors:   Universitas Padjadjaran;   University of Otago;   Harvard University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Moxifloxacin, Isoniazid, Rifampicin;   Drug: Rifampicin,Isoniazid,Pyrazinamide,Ethambutol Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Improving Rhode Island's Tuberculosis Preventive Services in Primary Care
Condition:   Latent Tuberculosis Intervention:   Other: TB Infection ECHO Sponsors:   Kent Hospital, Rhode Island;   National Institute of General Medical Sciences (NIGMS) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Moxifloxacin, Isoniazid, Rifampicin;   Drug: Rifampicin,Isoniazid,Pyrazinamide,Ethambutol Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Increasing Notifications of Tuberculosis From Private Practitioners
Condition:   Tuberculosis Intervention:   Other: INSTEP2 intervention package Sponsors:   Universitas Padjadjaran;   University of Otago;   Harvard University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
Condition:   Pulmonary Tuberculosis Interventions:   Drug: Moxifloxacin, Isoniazid, Rifampicin;   Drug: Rifampicin,Isoniazid,Pyrazinamide,Ethambutol Sponsor:   Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

Improving Rhode Island's Tuberculosis Preventive Services in Primary Care
Condition:   Latent Tuberculosis Intervention:   Other: TB Infection ECHO Sponsors:   Kent Hospital, Rhode Island;   National Institute of General Medical Sciences (NIGMS) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2019 Category: Research Source Type: clinical trials

A Phase 1 Trial to Evaluate the Male Reproductive Safety of Pretomanid in Healthy Volunteers
Conditions:   Tuberculosis, Pulmonary;   Tuberculosis, Multidrug-Resistant;   Tuberculosis, MDR;   Tuberculosis;   Drug-Resistant Tuberculosis Intervention:   Drug: Pretomanid Sponsor:   Global Alliance for TB Drug Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

Usability Study of IeHS in Indonesia
Conditions:   Human Immunodeficiency Virus;   Tuberculosis;   Interpersonal Relations;   Mobile Phone Use;   Adult Intervention:   Other: Integrated e-healthcare services (IeHS) web-based app Sponsors:   Bekasi City Public Hospital;   University of Groningen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

A Phase 1 Trial to Evaluate the Male Reproductive Safety of Pretomanid in Healthy Volunteers
Conditions:   Tuberculosis, Pulmonary;   Tuberculosis, Multidrug-Resistant;   Tuberculosis, MDR;   Tuberculosis;   Drug-Resistant Tuberculosis Intervention:   Drug: Pretomanid Sponsor:   Global Alliance for TB Drug Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

Usability Study of IeHS in Indonesia
Conditions:   Human Immunodeficiency Virus;   Tuberculosis;   Interpersonal Relations;   Mobile Phone Use;   Adult Intervention:   Other: Integrated e-healthcare services (IeHS) web-based app Sponsors:   Bekasi City Public Hospital;   University of Groningen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

A Phase 1 Trial to Evaluate the Male Reproductive Safety of Pretomanid in Healthy Volunteers
Conditions:   Tuberculosis, Pulmonary;   Tuberculosis, Multidrug-Resistant;   Tuberculosis, MDR;   Tuberculosis;   Drug-Resistant Tuberculosis Intervention:   Drug: Pretomanid Sponsor:   Global Alliance for TB Drug Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

Usability Study of IeHS in Indonesia
Conditions:   Human Immunodeficiency Virus;   Tuberculosis;   Interpersonal Relations;   Mobile Phone Use;   Adult Intervention:   Other: Integrated e-healthcare services (IeHS) web-based app Sponsors:   Bekasi City Public Hospital;   University of Groningen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

A Phase 1 Trial to Evaluate the Male Reproductive Safety of Pretomanid in Healthy Volunteers
Conditions:   Tuberculosis, Pulmonary;   Tuberculosis, Multidrug-Resistant;   Tuberculosis, MDR;   Tuberculosis;   Drug-Resistant Tuberculosis Intervention:   Drug: Pretomanid Sponsor:   Global Alliance for TB Drug Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

Usability Study of IeHS in Indonesia
Conditions:   Human Immunodeficiency Virus;   Tuberculosis;   Interpersonal Relations;   Mobile Phone Use;   Adult Intervention:   Other: Integrated e-healthcare services (IeHS) web-based app Sponsors:   Bekasi City Public Hospital;   University of Groningen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

A Phase 1 Trial to Evaluate the Male Reproductive Safety of Pretomanid in Healthy Volunteers
Conditions:   Tuberculosis, Pulmonary;   Tuberculosis, Multidrug-Resistant;   Tuberculosis, MDR;   Tuberculosis;   Drug-Resistant Tuberculosis Intervention:   Drug: Pretomanid Sponsor:   Global Alliance for TB Drug Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

Usability Study of IeHS in Indonesia
Conditions:   Human Immunodeficiency Virus;   Tuberculosis;   Interpersonal Relations;   Mobile Phone Use;   Adult Intervention:   Other: Integrated e-healthcare services (IeHS) web-based app Sponsors:   Bekasi City Public Hospital;   University of Groningen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

A Phase 1 Trial to Evaluate the Male Reproductive Safety of Pretomanid in Healthy Volunteers
Conditions:   Tuberculosis, Pulmonary;   Tuberculosis, Multidrug-Resistant;   Tuberculosis, MDR;   Tuberculosis;   Drug-Resistant Tuberculosis Intervention:   Drug: Pretomanid Sponsor:   Global Alliance for TB Drug Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

Usability Study of IeHS in Indonesia
Conditions:   Human Immunodeficiency Virus;   Tuberculosis;   Interpersonal Relations;   Mobile Phone Use;   Adult Intervention:   Other: Integrated e-healthcare services (IeHS) web-based app Sponsors:   Bekasi City Public Hospital;   University of Groningen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

A Phase 1 Trial to Evaluate the Male Reproductive Safety of Pretomanid in Healthy Volunteers
Conditions:   Tuberculosis, Pulmonary;   Tuberculosis, Multidrug-Resistant;   Tuberculosis, MDR;   Tuberculosis;   Drug-Resistant Tuberculosis Intervention:   Drug: Pretomanid Sponsor:   Global Alliance for TB Drug Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

Usability Study of IeHS in Indonesia
Conditions:   Human Immunodeficiency Virus;   Tuberculosis;   Interpersonal Relations;   Mobile Phone Use;   Adult Intervention:   Other: Integrated e-healthcare services (IeHS) web-based app Sponsors:   Bekasi City Public Hospital;   University of Groningen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials

A Phase 1 Trial to Evaluate the Male Reproductive Safety of Pretomanid in Healthy Volunteers
Conditions:   Tuberculosis, Pulmonary;   Tuberculosis, Multidrug-Resistant;   Tuberculosis, MDR;   Tuberculosis;   Drug-Resistant Tuberculosis Intervention:   Drug: Pretomanid Sponsor:   Global Alliance for TB Drug Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2019 Category: Research Source Type: clinical trials